CAT and Alzheimer disease: The first consists of randomly selecting Wistar rats weighing 230 ± 20 g and administering 4.2–50 mg/kg of AlCl3 dissolved in water ip for 28–42 days (depending on the experimental design); 24 h later, behavioral assessment tests, including the MWM, are performed, and 24 h later, biochemical tests of MDA levels, superoxide dismutase activity, and catalase activity) [120,121] are carried out to screen individuals that mimic the symptomatology and neuropathology of AD.